• Please log in or register to access this feature.

The Cutting Edge

THE ENDOCANNABINOID SYSTEM PROVIDES AN AVENUE FOR EVIDENCE-BASED TREATMENT DEVELOPMENT FOR PTSD

  1. Alexander Neumeister M.D*

Article first published online: 5 DEC 2012

DOI: 10.1002/da.22031

Issue

Depression and Anxiety

Depression and Anxiety

Volume 30, Issue 2, pages 93–96, February 2013

Additional Information

How to Cite

Neumeister, A. (2013), THE ENDOCANNABINOID SYSTEM PROVIDES AN AVENUE FOR EVIDENCE-BASED TREATMENT DEVELOPMENT FOR PTSD. Depress. Anxiety, 30: 93–96. doi: 10.1002/da.22031

Author Information

*Correspondence to: Alexander Neumeister, M.D., Professor of Psychiatry and Radiology, New York University School of Medicine, Director, Molecular Imaging Program for Anxiety & Mood Disorders, One Park Avenue, 8th floor, room 225, New York, NY 10016. E-mail: alexander.neumeister@nyumc.org

Publication History

  1. Issue published online: 25 JAN 2013
  2. Article first published online: 5 DEC 2012

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (639K)

First page of article

First page of THE ENDOCANNABINOID SYSTEM PROVIDES AN AVENUE FOR EVIDENCE‐BASED TREATMENT DEVELOPMENT FOR PTSD
View Full Article (HTML) Get PDF (639K)